Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001649553-25-000067·CVI Investments, Inc.
Schedule 13G ownership disclosure
PASITHEA THERAPEUTICS CORP
Common Stock, $0.0001 par value per share · CUSIP: 70261F202
Event date: 2025-05-06
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 627,319 · Class: 9.9%
- Heights Capital Management, Inc.
Shares: 627,319 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000067
- Form type
- SCHEDULE 13G
- Filer
- CVI Investments, Inc.
- CIK
- CIK 1649553
- Filed
- May 12, 2025
- Reporting period
- May 06, 2025
- Description
- Schedule 13G beneficial ownership